Study drug resistance in very sick children with infections
Part of Infections clinical trials.
This trial enrolls children in the pediatric intensive care unit (PICU) who have a severe infection. It aims to better understand germs and drug resistance so future treatments can be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child who is currently in the PICU (pediatric intensive care unit)
- A doctor has confirmed you have a severe infection
- The study is for patients with an active infection (not just being observed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how children with severe bacterial infections that start outside the hospital are treated in the pediatric intensive care unit. It helps doctors learn more about these infections to improve care for kids.
This trial builds a shared medical data system to better understand severe pneumonia and sepsis in children. Your participation helps clinicians and researchers learn from many cases to improve future care.
This study looks at factors that make some hospitalized children in the pediatric intensive care unit (PICU) develop or carry germs called carbapenem-resistant Enterobacteriaceae. It aims to understand who is at higher risk and why, which may help prevent infections in the future.
This trial measures how anti-infective medicines move through a child’s body while they are in the hospital or during follow-up. The goal is to better understand dosing and drug exposure in critically ill children.
This study looks at how antibiotics are used in the pediatric intensive care unit (PICU) to improve treatment and reduce unnecessary use. It may help ensure your child gets the right antibiotics if needed.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
Hear when a new Severe Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.